Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets. | Front Pharmacol | 2022 | 35983376 | PubTator, text mining | PubMed |
| Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment. | NPJ Precis Oncol | 2022 | 35982235 | PubTator, text mining | PubMed |
| N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation. | Clin Transl Med | 2022 | 35979628 | PubTator, text mining | PubMed |
| Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma. | Front Oncol | 2022 | 35978835 | PubTator, text mining | PubMed |
| SH3 domain regulation of RhoGAP activity: Crosstalk between p120RasGAP and DLC1 RhoGAP. | Nat Commun | 2022 | 35970859 | PubTator, text mining | PubMed |
| Antineoplastic Effects of Ankaferd Hemostat. | Biomed Res Int | 2022 | 35958818 | PubTator, text mining | PubMed |
| Induced pluripotent stem cell-derived smooth muscle cells to study cardiovascular calcification. | Front Cardiovasc Med | 2022 | 35958427 | PubTator, text mining | PubMed |
| A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers. | Int J Mol Sci | 2022 | 35955727 | PubTator, text mining | PubMed |
| The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers-What Should a Urologist Really Know? | Int J Environ Res Public Health | 2022 | 35955004 | PubTator, text mining | PubMed |
| Comparing the quality of care for long-term ventilated individuals at home versus in shared living communities: a convergent parallel mixed-methods study. | BMC Nurs | 2022 | 35953810 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases. | Clin Microbiol Infect | 2022 | 35940566 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages in Canine Oral and Cutaneous Melanomas and Melanocytomas: Phenotypic and Prognostic Assessment. | Front Vet Sci | 2022 | 35937296 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma. | Front Immunol | 2022 | 35935940 | PubTator, text mining | PubMed |
| Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms. | Front Pharmacol | 2022 | 35935861 | PubTator, text mining | PubMed |
| [Outpatient before inpatient treatment?-Reality of care and economic analysis for minor urological interventions in Germany between 2013 and 2018]. | Urologie | 2022 | 35925103 | PubTator, text mining | PubMed |
| Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer care. | BMJ Health Care Inform | 2022 | 35922094 | PubTator, text mining | PubMed |
| Optimization of Ultrafast Proteomics Using an LC-Quadrupole-Orbitrap Mass Spectrometer with Data-Independent Acquisition. | J Proteome Res | 2022 | 35914019 | PubTator, text mining | PubMed |
| Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs. | Oncoimmunology | 2022 | 35909944 | PubTator, text mining | PubMed |
| Knowledge-graph-based cell-cell communication inference for spatially resolved transcriptomic data with SpaTalk. | Nat Commun | 2022 | 35908020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=38